Effects of Water-soluble Olive Extract Supplementation
This study has been completed.
Sponsor:
University of Texas at Austin
Collaborator:
DSM Nutritional Products, Inc.
Information provided by (Responsible Party):
University of Texas at Austin
ClinicalTrials.gov Identifier:
NCT01113827
First received: April 28, 2010
Last updated: March 23, 2012
Last verified: February 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Six weeks of supplementation of an olive extract will:
- Improve antioxidant status
- Reduce inflammation
- Reduce muscle damage
- Improve exercise performance
- Improve exercise recovery as compared to a placebo.
| Condition | Intervention |
|---|---|
|
Healthy |
Dietary Supplement: Olive Extract Dietary Supplement: Placebo |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Investigator, Outcomes Assessor) Primary Purpose: Basic Science |
| Official Title: | Effects of Water-soluble Olive Extract on Antioxidant Status, Exercise Performance, Muscle Metabolism, Muscle Damage and Inflammation |
Resource links provided by NLM:
Further study details as provided by University of Texas at Austin:
Primary Outcome Measures:
- Improved Antioxidant Status [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Reduced Inflammation [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]
| Enrollment: | 61 |
| Study Start Date: | February 2010 |
| Study Completion Date: | February 2012 |
| Primary Completion Date: | July 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Active Comparator: 150mg olive extract |
Dietary Supplement: Olive Extract
Capsule form ingested 1x/day for 6 weeks
|
| Active Comparator: 50mg olive extract |
Dietary Supplement: Olive Extract
Capsule form ingested 1x/day for 6 weeks
|
| Placebo Comparator: Placebo control |
Dietary Supplement: Placebo
Placebo
|
Eligibility| Ages Eligible for Study: | 20 Years to 35 Years |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Recreational exerciser
- BMI <= 30
- Non-smoker
Exclusion Criteria:
- Blood pressure over 140/90
- Type I or Type II diabetes
- Renal, hepatic or cardiac disease
- Current infectious disease
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01113827
Locations
| United States, Texas | |
| The University of Texas at Austin | |
| Austin, Texas, United States, 78712 | |
Sponsors and Collaborators
University of Texas at Austin
DSM Nutritional Products, Inc.
Investigators
| Principal Investigator: | John Ivy, Ph.D. | The University of Texas at Austin |
More Information
No publications provided
| Responsible Party: | University of Texas at Austin |
| ClinicalTrials.gov Identifier: | NCT01113827 History of Changes |
| Other Study ID Numbers: | 2009-09-01-OLIV |
| Study First Received: | April 28, 2010 |
| Last Updated: | March 23, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of Texas at Austin:
|
Olive antioxidant exercise |
inflammation recovery Healthy men |
Additional relevant MeSH terms:
|
Inflammation Pathologic Processes Antioxidants Molecular Mechanisms of Pharmacological Action |
Pharmacologic Actions Protective Agents Physiological Effects of Drugs |
ClinicalTrials.gov processed this record on June 17, 2013